Safety Information for Pregnant Women
Pregnancy Safety Categories
Promethazine is classified as pregnancy category C, meaning studies in animals have shown potential risks, but human studies are limited. The medicine crosses the placenta, so any decision to use promethazine during pregnancy should involve careful risk-benefit assessment with your healthcare provider.
First Trimester Considerations
During early pregnancy (weeks 1-12), organ development occurs rapidly. Whilst promethazine hasn't been definitively linked to birth defects, some studies suggest possible associations with certain conditions. Your GP may recommend alternative treatments for allergies or nausea during this critical period.
Second and Third Trimester Use
Promethazine is more commonly prescribed during later pregnancy stages. It may help manage severe morning sickness, pregnancy-related allergies, or sleep disturbances. EverydayMeds stocks both Phenergan 25mg tablets and Phenergan elixir (5mg/5ml), allowing flexible dosing options under medical guidance.
Potential Benefits During Pregnancy
Healthcare providers might consider promethazine for pregnant women experiencing severe nausea and vomiting (hyperemesis gravidarum), hay fever symptoms, or significant sleep disruption. The sedating properties can provide relief when other treatments prove insufficient.
Labour and Delivery Considerations
Promethazine use near delivery requires caution. The medication can cross into breast milk and may affect newborns, potentially causing breathing difficulties or excessive sleepiness. Your midwife or obstetrician will advise on timing if promethazine treatment is necessary.
Breastfeeding Information
Small amounts of promethazine pass into breast milk. Whilst generally considered compatible with breastfeeding, monitor your baby for unusual sleepiness or feeding difficulties. Discuss continuation of treatment with your healthcare provider post-delivery.
